PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

128 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
81.
Frank, O.* et al.: Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. J. Virol. 79, 10890-10901 (2005)
82.
Kelly, G.K.* et al.: Epstein-barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A,-3B and -3C expression in burkitt's lymphoma cells and with increased resistance to apoptosis. J. Virol. 79, 10709-10717 (2005)
83.
Ludwig, H.* et al.: Role of viral factor E3L in modified vaccinia virus Ankara infection of human HeLa cells: Regulation of the virus life cycle and identification of differentially expressed host genes. J. Virol. 79, 2584-2596 (2005)
84.
Maier, S. et al.: A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent. J. Virol. 79, 8784-8792 (2005)
85.
Najjar, I.* ; Schlee, M. & Bornkamm, G.W.: Latent membrane protein 1 regulates STAT1 through NF-kB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells. J. Virol. 79, 4936-4943 (2005)
86.
Nielsen, A.A.* ; Sorensen, A.B.* ; Schmidt, J. & Pedersen, F.S.*: Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomaganesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair. J. Virol. 79, 67-78 (2005)
87.
Peng, R.* ; Moses, S.C.* ; Tan, J.* ; Kremmer, E. & Ling, P.D.*: The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J. Virol. 79, 4492-4505 (2005)
88.
Seifarth, W.* et al.: Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. J. Virol. 79, 341-352 (2005)
89.
Smulevitch, S.* et al.: Structural and functional analysis of the RNA transport element, a member of an extensive family present in the mouse genome. J. Virol. 79, 2356-2365 (2005)
90.
Gordadze, A.V.* et al.: EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance. J. Virol. 78, 3919-3929 (2004)
91.
Lee, J.M.* et al.: EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. J. Virol. 78, 12694-12697 (2004)
92.
Ruvolo, V.* et al.: Functional analysis of Epstein-Barr virus SM protein: Identification of amino acids essential for structure, transactivation, splicing inhibition and virion production. J. Virol. 78, 2-13 (2004)
93.
Schlee, M. et al.: Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: Activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary b cells by EBV. J. Virol. 78, 3941-3952 (2004)
94.
Stewart, J.P.* et al.: In vivo function of a gammaherpesvirus virion glycoprotein: Influence on B-cell infection and mononucleosis. J. Virol. 78, 10449-10459 (2004)
95.
Sørensen, K.D.* ; Quintanilla-Martinez, L. ; Kunder, S. ; Schmidt, J. & Pedersen, F.S.*: Mutation of all runx (AML1/Core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns. J. Virol. 78, 13216-13231 (2004)
96.
Brinkmann, M.M.* et al.: Activation of Mitogen-Activated Protein Kinase and NF-kB Pathways by a Kaposi's Sarcoma- Associated Herpesvirus K15 Membrane Protein. J. Virol. 77, 9346-9358 (2003)
97.
Dudziak, D. et al.: Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-kB Signaling Pathway. J. Virol. 77, 8290-8298 (2003)
98.
Herzer, K.* et al.: Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity. J. Virol. 77, 8299-8309 (2003)
99.
Hornemann, S. et al.: Replication of Modified Vaccinia Virus Ankara in Primary Chicken Embryo Fibroblasts Requires Expression of the Interferon Resistance Gene E3L. J. Virol. 77, 8394-8407 (2003)
100.
Öhlschläger, P.* et al.: Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. J. Virol. 77, 4635-4645 (2003)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... ▶▶ ▶▮